Skip to main content
TipRanks
Go Ultimate75% OFF

China Shineway Pharmaceutical Group Limited (2877) Stock Price & Analysis

0 Followers

2877 Stock Chart & Stats

HK$7.60-HK$0.03(-0.39%)
At close: 4:00 PM GMT+8
HK$7.5HK$8HK$8.5Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
HKD 7.57 - HKD 7.64
52-Week Range
HKD 7.12 - HKD 10.47
Previous Close
HKD 7.63
Volume
N/A
Average Volume (3M)
995.91K
Market Cap
HKD 5.74B
Enterprise Value
-HKD 2.78B
Total Cash (Recent Filing)
HKD 7.54B
Total Debt (Recent Filing)
HKD 312.23M
Price to Earnings (P/E)
6.2
Beta
0.47
Next Earnings
Mar 30, 2027 (Est.)
EPS Estimate
N/A
Dividend Yield
16.46%

Bulls Say, Bears Say

Bulls Say

High Profitability

Sustained high gross and operating margins indicate strong product economics in the company’s proprietary TCM portfolio. This profitability provides resilience against cost pressure and supports continued investment in research, manufacturing quality, hospital access, and distribution over the coming quarters.

Very Low Leverage

Minimal leverage materially limits interest burdens, refinancing exposure, and balance-sheet stress during weaker demand periods. The conservative capital structure preserves financial flexibility to fund operations, product development, and shareholder distributions without relying heavily on external borrowing.

Positive Cash Generation

Consistently positive free cash flow indicates that reported profitability is being converted into internally generated funds. Stronger 2025 cash generation can support working capital, research and development, manufacturing investment, and distributions while reducing dependence on debt financing.

Bears Say

Revenue Contraction

The sustained weakening in revenue momentum signals pressure on product volumes, pricing, or mix across the TCM portfolio. If contraction persists, lower operating scale could reduce the company’s ability to absorb fixed manufacturing, quality-control, and commercial costs.

Margin Softening

Although margins remain healthy, the decline from the 2023 peak suggests that the company’s earnings conversion is not fully stable. Continued pressure from product mix, pricing, or operating costs could reduce the benefit of its otherwise strong gross-margin structure over the next several quarters.

Volatile Cash-Flow Growth

Year-to-year volatility in free cash flow makes the timing and reliability of internally funded investment less predictable. Even with positive cash generation, uneven conversion can complicate planning for research, production capacity, commercial spending, and shareholder returns.

China Shineway Pharmaceutical Group Limited News

2877 FAQ

What was China Shineway Pharmaceutical Group Limited’s price range in the past 12 months?
China Shineway Pharmaceutical Group Limited lowest stock price was HK$7.12 and its highest was HK$10.47 in the past 12 months.
What is China Shineway Pharmaceutical Group Limited’s market cap?
China Shineway Pharmaceutical Group Limited’s market cap is HK$5.74B.
When is China Shineway Pharmaceutical Group Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were China Shineway Pharmaceutical Group Limited’s earnings last quarter?
China Shineway Pharmaceutical Group Limited released its earnings results on Aug 27, 2026. The company reported HK$0.639 earnings per share for the quarter.
Is China Shineway Pharmaceutical Group Limited overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does China Shineway Pharmaceutical Group Limited pay dividends?
China Shineway Pharmaceutical Group Limited pays a semiannual dividend of HK$0.995 which represents an annual dividend yield of 16.46%. See more information on China Shineway Pharmaceutical Group Limited dividends here
What is China Shineway Pharmaceutical Group Limited’s EPS estimate?
China Shineway Pharmaceutical Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Shineway Pharmaceutical Group Limited have?
China Shineway Pharmaceutical Group Limited has 827,000,000 shares outstanding.
What happened to China Shineway Pharmaceutical Group Limited’s price movement after its last earnings report?
China Shineway Pharmaceutical Group Limited reported an EPS of HK$0.639 in its last earnings report. Following the earnings report the stock price went up 5.99%.
Which hedge fund is a major shareholder of China Shineway Pharmaceutical Group Limited?
Currently, no hedge funds are holding shares in HK:2877
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology